7-amino-6-benzoyl-1,4-benzodioxane | 164526-15-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 7-amino-6-benzoyl-1,4-benzodioxane
• 英文别名: (7-amino-2,3-dihydro-1,4-benzodioxin-6-yl)-(phenyl)methanone；2-amino-4,5-ethylenedioxybenzophenone；6-amino-7-benzoyl-1,4-benzodioxane；(7-Amino-2,3-dihydro-benzo[1,4]dioxin-6-yl)-phenyl-methanone；(6-amino-2,3-dihydro-1,4-benzodioxin-7-yl)-phenylmethanone
• CAS: 164526-15-2
• 化学式: C₁₅H₁₃NO₃
• mdl: MFCD01070795
• 分子量: 255.273
• InChiKey: ALKQZAYAWNIANE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  61.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  7-amino-6-benzoyl-1,4-benzodioxane 在 盐酸 、 sodium tetrahydroborate 、 三氟化硼乙醚 、 sodium nitrite 作用下， 以 十二烷 、 乙醇 、 二氯甲烷 、 水 、 乙酸乙酯 为溶剂， 反应 1.0h， 生成 4-(8-phenyl-2,3-dihydro-6H-[1,4]dioxino[2,3-f]indol-7-yl)but-3-en-2-one
  参考文献：
  名称：

  A Simple Route to Polysubstituted Indoles Exploiting Azide Induced Furan Ring Opening

  摘要：

  A straightforward, efficient indole synthesis based on thermolysis of 2-(2-azidobenzyl)furans with attack of the formed nitrene moiety onto the ipso position of furan ring has been developed. The cyclization is accompanied by furan ring opening and affords indoles with a 2-acylvinyl substituent suitable for further modifications.

  DOI：

  10.1021/ol5018504
• 作为产物：
  描述：

  2,3-dihydro-1,4-benzodioxin-6-yl(phenyl)methanone 在 硝酸 、 铁粉 、 溶剂黄146 作用下， 以 水 、 乙酸乙酯 为溶剂， 反应 6.5h， 生成 7-amino-6-benzoyl-1,4-benzodioxane
  参考文献：
  名称：

  Simple route to 3-(2-indolyl)-1-propanones via a furan recyclization reaction

  摘要：

  A simple route to 1-R-3-(2-indolyl)-1-propanones has been elaborated based on recyclization of 2-(2-aminobenzyl)furan derivatives. Being a modification of the Reissert indole synthesis, our approach employs the furan ring as a source of carbonyl function. This approach is general and allows varying of substituents in aromatic ring as well as in 3-position of indole nucleus. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2006.10.056

文献信息

• Substituted quinazolines and analogs and use thereof
  申请人：Euro-Celtique S.A.

  公开号：US06465472B1

  公开（公告）日：2002-10-15

  The invention relates to novel quinazolines and heterocycles which are antagonists or positive modulators of AMPA receptors, and the use thereof for treating, preventing or ameliorating neuronal loss associated with stroke, global and focal ischemia, CNS trauma, hypoglycemia and surgery, as well as treating or ameliorating neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, Parkinson's disease and Down's syndrome, treating, preventing or ameliorating the adverse consequences of the overstimulation of the excitatory amino acids, treating, preventing or ameliorating anxiety, psychosis, convulsions, chronic pain, glaucoma, retinitis, urinary incontinence, muscular spasm and inducing anesthesia, as well as for treating or ameliorating the adverse consequences of excitatory amino acid deficiency such as schizophrenia, myoclonus. Alzheimer's disease and malnutrition and neural maldevelopment, and as cognition and learning enhancers.

  该发明涉及新型喹唑啉和杂环化合物，它们是AMPA受体的拮抗剂或正调节剂，用于治疗、预防或改善与中风、全脑和局部缺血、中枢神经系统创伤、低血糖和手术相关的神经元丧失，以及治疗或改善包括阿尔茨海默病、肌萎缩侧索硬化、亨廷顿病、帕金森病和唐氏综合征在内的神经退行性疾病，治疗、预防或改善兴奋性氨基酸过度刺激的不良后果，治疗、预防或改善焦虑、精神病、抽搐、慢性疼痛、青光眼、视网膜炎、尿失禁、肌肉痉挛和诱导麻醉，以及治疗或改善兴奋性氨基酸缺乏的不良后果，如精神分裂症、肌阵挛、阿尔茨海默病和营养不良和神经发育不良，以及作为认知和学习增强剂。
• Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
  申请人：——

  公开号：US20040152888A1

  公开（公告）日：2004-08-05

  The invention concerns novel benzodiazepine derivatives and their uses in the field of therapeutics particularly for treating pathologies involving the activity of a cyclic nucleotide phosphodiesterase. It also concerns methods for preparing them and novel synthesis intermediates. The inventive compounds more particularly correspond to general formula (I): 1

  这项发明涉及新型苯二氮卓类衍生物及其在治疗领域中的用途，特别用于治疗涉及环核苷酸磷酸二酯酶活性的病理。它还涉及制备它们的方法和新型合成中间体。这些创新化合物更特别地对应于一般式(I)：1
• Substituted quinazolines and analogs and the use thereof
  申请人：Euro-Celtique S.A.

  公开号：US20030033089A1

  公开（公告）日：2003-02-13

  The invention relates to novel quinazolines and heterocycles which are antagonists or positive modulators of AMPA receptors, and the use thereof for treating, preventing or ameliorating neuronal loss associated with stroke, global and focal ischemia, CNS trauma, hypoglycemia and surgery, as well as treating or ameliorating neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, Parkinson's disease and Down's syndrome, treating, preventing or ameliorating the adverse consequences of the overstimulation of the excitatory amino acids, treating, preventing or ameliorating anxiety, psychosis, convulsions, chronic pain, glaucoma, retinitis, urinary incontinence, muscular spasm and inducing anesthesia, as well as for treating or ameliorating the adverse consequences of excitatory amino acid deficiency such as schizophrenia, myoclonus, Alzheimer's disease and malnutrition and neural maldevelopment, and as cognition and learning enhancers.

  本发明涉及新型的喹唑啉和杂环化合物，它们是AMPA受体的拮抗剂或正向调节剂，并用于治疗、预防或改善与中风、全局和局部缺血、中枢神经系统创伤、低血糖和手术相关的神经元丧失，以及治疗或改善包括阿尔茨海默病、肌萎缩性侧索硬化、亨廷顿病、帕金森病和唐氏综合症在内的神经退行性疾病，治疗、预防或改善兴奋性氨基酸过度刺激的不良后果，治疗、预防或改善焦虑、精神病、惊厥、慢性疼痛、青光眼、视网膜炎、尿失禁、肌肉痉挛和诱导麻醉，以及治疗或改善兴奋性氨基酸缺乏的不良后果，如精神分裂症、肌阵挛、阿尔茨海默病和营养不良和神经发育不良，并作为认知和学习增强剂。
• Synthesis of 1,3-dihydro-5(r)-7,8-ethylenedioxy-2h-1,4-benzo-diazepin-2-ones
  作者：S. S. Mochalov、D. V. Kosynkin、I. D. Yudin、V. N. Atanov、Yu. S. Shabarov、N. S. Zefirov

  DOI：10.1007/bf01169826

  日期：1994.5
• 4H-3,1-benzoxazines from o-aminoacylbenzenes
  作者：G. A. Gazzaeva、M. I. Khasanov、S. S. Mochalov、N. S. Zefirov

  DOI：10.1007/s10593-007-0129-3

  日期：2007.6